ANGELA BARRILLEAUX
Summary
Strategic market access leader with a strong record in formulary negotiations and payer strategy across pharmaceutical and device sectors. Established partnerships with C-suite executives to enhance access and shape clinical policy. Proficient in product life-cycle management and U.S. healthcare distribution, successfully leading cross-functional teams to achieve sustainable growth.
Overview
2026
2026
years of professional experience
Work History
Senior Access & Reimbursement Manager
United Therapeutics
2023 - Current
- Directed access and reimbursement strategy to improve formulary coverage for rare disease therapies.
- Collaborated with cross-functional teams in Government Affairs, Policy, Managed Markets, and Medical Affairs to unify payer strategies.
- Evaluated contract and payer performance metrics to identify opportunities for enhancement.
- Presented payer value propositions and health economics data to drive positive policy outcomes.
- Partnered with specialty pharmacies (Accredo, CVS) to optimize acquisition processes and eliminate reimbursement barriers.
- Streamlined tracking and reporting of payer policy data, leading to increased payer coverage.
Director, National Accounts & Reimbursement
Heron Therapeutics
2022 - 2023
- Directed market access strategy for national and regional payers, PBMs, and employer groups.
- Secured formulary wins with major national payers including Aetna/CVS, UHC, Cigna, Highmark BCBS, and Medicaid programs.
- Collaborated with MACs to establish positive medical policies supporting product utilization.
- Partnered cross-functionally to align contracting and pricing strategies across business units.
- Drove revenue growth exceeding corporate targets for gross-to-net performance through formulary wins.
National Account Director, Market Access & Reimbursement
Tris Pharmaceuticals
2020 - 2022
- Executed business plans for key national accounts and PBMs to secure product access.
- Led negotiations and contracting with UHC, VA, DoD, Medicare, Medicaid, and major BCBS plans.
- Analyzed contract performance and rebate data to identify growth opportunities.
- Achieved a 45% revenue increase through effective payer contract execution.
- Chaired a Contract Working Group to streamline cross-functional strategy, and enhance accountability.
National Account Director
Ferring Pharmaceuticals
2012 - 2016
- Negotiated formulary contracts to facilitate $100M Entyvio launch.
- Achieved 125% of launch target within three months, attaining top national market share.
- Recognized with Takeda's Cresset Achievement Award for ranking in top 5% nationally for two consecutive years.
- Established partnerships with Specialty Pharmacy and IDN to improve pull-through and reimbursement results.
Education
Bachelor of Science -
University of Louisiana
Skills
- Formulary negotiations
- Payer engagement strategies
- Contract development
- Performance analytics
- RFP management
- Clinical policy advocacy
- Value proposition communication
- Business planning
- Reimbursement strategy
Timeline
Senior Access & Reimbursement Manager
United Therapeutics
2023 - Current
Director, National Accounts & Reimbursement
Heron Therapeutics
2022 - 2023
National Account Director, Market Access & Reimbursement
Tris Pharmaceuticals
2020 - 2022
National Account Director
Ferring Pharmaceuticals
2012 - 2016
Bachelor of Science -
University of Louisiana